SWOT analysis of regulation in the advertising of medical products in Bulgaria

SWOT analysis of regulation in the advertising of medical products in Bulgaria

Oral presentation

Angel Dakov
Faculty of Chemistry and Pharmacy, University of Sofia “St. Kliment Ohridski”, Sofia

The report will mark the main points of Chapter XI of the Medicinal Products in Human Medicines Act - advertising of medicinal products, and why the need for such a legal framework has emerged. The SWOT analysis of the regulation of the advertising of medicinal products provides a basis for assessing its strengths and weaknesses at the moment and the opportunities and threats to its future development. They should be taken into account on the basis of a strategic comparison of the Bulgarian regulation, which is fully synchronized with that of the European Union and of countries outside its jurisdictions. The Internet will also be considered as an unlimited opportunity for the development of drug advertising.